ATE1019T1 - Hyaluronidase und seine herstellung. - Google Patents

Hyaluronidase und seine herstellung.

Info

Publication number
ATE1019T1
ATE1019T1 AT79101420T AT79101420T ATE1019T1 AT E1019 T1 ATE1019 T1 AT E1019T1 AT 79101420 T AT79101420 T AT 79101420T AT 79101420 T AT79101420 T AT 79101420T AT E1019 T1 ATE1019 T1 AT E1019T1
Authority
AT
Austria
Prior art keywords
hyaluronidase
manufacture
chondroitin
hexosaminidase
endo
Prior art date
Application number
AT79101420T
Other languages
English (en)
Inventor
Keizo Yoshida
Takashi Musashiseki Mansion 604 Fujii
Hiroyuki Kikuchi
Original Assignee
Fujisawa Pharmaceutical Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co. Ltd. filed Critical Fujisawa Pharmaceutical Co. Ltd.
Application granted granted Critical
Publication of ATE1019T1 publication Critical patent/ATE1019T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT79101420T 1978-05-11 1979-05-10 Hyaluronidase und seine herstellung. ATE1019T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53056313A JPS6033474B2 (ja) 1978-05-11 1978-05-11 新規なヒアルロニダ−ゼbmp−8231およびその製造法
EP79101420A EP0005751B1 (de) 1978-05-11 1979-05-10 Hyaluronidase und seine Herstellung

Publications (1)

Publication Number Publication Date
ATE1019T1 true ATE1019T1 (de) 1982-05-15

Family

ID=13023655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79101420T ATE1019T1 (de) 1978-05-11 1979-05-10 Hyaluronidase und seine herstellung.

Country Status (5)

Country Link
US (1) US4258134A (de)
EP (1) EP0005751B1 (de)
JP (1) JPS6033474B2 (de)
AT (1) ATE1019T1 (de)
DE (1) DE2962780D1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801475A (en) * 1984-08-23 1989-01-31 Gregory Halpern Method of hydrophilic coating of plastics
GB8504025D0 (en) * 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
SE456245B (sv) * 1986-07-09 1988-09-19 Pharmacia Ab Enzympreparation innehallande krillhyaluronidas
JP2699078B2 (ja) * 1987-12-23 1998-01-19 北里研究所(社団法人) ムシン分解酵素及びその製造法
US6610292B2 (en) 1995-11-22 2003-08-26 Ista Pharmaceuticals, Inc. Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
US5866120A (en) * 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
KR20010041806A (ko) * 1998-03-09 2001-05-25 에드워드 에이취. 댄스 효소 각막교정술에 사용되는 각막 경화제의 용도
BR9910574A (pt) 1998-04-30 2001-09-11 Maruha Corp Compostos tendo derivado de ácido glicurÈnico e derivado de glicosamina em sua estrutura, método para a produção dos compostos, e uso dos compostos
RU2174557C1 (ru) * 2000-11-22 2001-10-10 Предприятие по производству бакпрепаратов научно-исследовательского института эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН Способ получения гиалуронидазы стрептококковой
PL1603541T5 (pl) 2003-03-05 2013-06-28 Halozyme Inc Rozpuszczalna glikoproteina o aktywności hialuronidazy (sHASEGP), sposób jej wytwarzania, zastosowanie i zawierające ją kompozycje farmaceutyczne
MXPA03011987A (es) 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
MY152979A (en) 2008-01-09 2014-12-15 Sanofi Aventis Deutschland Novel insulin derivatives having an extremely delayed time-action profile
PL3228320T3 (pl) 2008-10-17 2020-06-01 Sanofi-Aventis Deutschland Gmbh Kombinacja insuliny i agonisty GLP-1
IT1396003B1 (it) * 2009-05-14 2012-11-09 Fidia Farmaceutici Ialuronidasi extracellulare da streptomyces koganeiensis
TWI520745B (zh) * 2009-07-06 2016-02-11 賽諾菲阿凡提斯德意志有限公司 含甲硫胺酸之胰島素製劑
CN102711805A (zh) 2009-11-13 2012-10-03 赛诺菲-安万特德国有限公司 包含glp-1激动剂、胰岛素和甲硫氨酸的药物组合物
SI2498801T1 (en) 2009-11-13 2018-06-29 Sanofi-Aventis Deutschland Gmbh A pharmaceutical composition containing desPro36Exendin-4 (1-39) -Lys6-NH2 and methionine
CZ2009835A3 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
CZ302504B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
HUE031181T2 (en) 2010-08-30 2017-06-28 Sanofi Aventis Deutschland Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
KR101983982B1 (ko) 2011-08-29 2019-05-30 사노피-아벤티스 도이칠란트 게엠베하 2형 당뇨병 환자의 혈당 조절에 사용하기 위한 약제학적 병용물
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CZ303879B6 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
AU2013299415B2 (en) 2012-08-10 2017-07-13 Osio Corporation d/b/a Yolia Health Contact lens use in the treatment of an ophthalmologic condition
CZ2012664A3 (cs) 2012-09-27 2013-11-13 Contipro Biotech S.R.O. Enzym hyaluronan-lyáza, zpusob jeho výroby, pouzití a zpusob prípravy nízkomolekulárního hyaluronanu
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
TWI780236B (zh) 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
ES2708759T3 (es) 2013-05-13 2019-04-11 Momenta Pharmaceuticals Inc Procedimientos para el tratamiento de la neurodegeneración
ITMI20130992A1 (it) 2013-06-17 2014-12-18 Fidia Farmaceutici Ialuronidasi batterica e metodo per la sua produzione
EP3058084A4 (de) 2013-10-16 2017-07-05 Momenta Pharmaceuticals, Inc. Sialylierte glycoproteine
KR20160104724A (ko) 2014-01-09 2016-09-05 사노피 인슐린 유사체 및/또는 인슐린 유도체의 안정화된 약제학적 제형
KR20160101195A (ko) 2014-01-09 2016-08-24 사노피 인슐린 아스파트의 안정화된 약제학적 제형
MX2016008978A (es) 2014-01-09 2016-10-04 Sanofi Sa Formulaciones farmaceuticas de analogos de insulina y/o derivados de insulina estabilizadas y que estan libres de glicerol.
CZ305153B6 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
JP6970615B2 (ja) 2014-12-12 2021-11-24 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング インスリングラルギン/リキシセナチド固定比処方
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
CZ306479B6 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1946682A1 (de) 1968-09-21 1971-01-28 Amano Pharma Co Ltd Verfahren zur Herstellung von Hyaluronidase
US3728223A (en) * 1971-10-08 1973-04-17 Amano Pharma Co Ltd Production of hyaluronidase from a strain of streptomyces
JPS5413510B2 (de) * 1973-08-28 1979-05-31
SU513075A1 (ru) * 1974-09-09 1976-05-05 Московский технологический институт пищевой промышленности Способ получени гиалуронидазы

Also Published As

Publication number Publication date
US4258134A (en) 1981-03-24
EP0005751A1 (de) 1979-12-12
JPS6033474B2 (ja) 1985-08-02
EP0005751B1 (de) 1982-05-12
JPS54147997A (en) 1979-11-19
DE2962780D1 (en) 1982-07-01

Similar Documents

Publication Publication Date Title
ATE1019T1 (de) Hyaluronidase und seine herstellung.
ATE22104T1 (de) Herstellung von pyrrolo-(3,4-c)-pyrrolen.
FI73995B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 6,11-dihydro-dibenso-/b,e/-tiepin-11-n-alkyl- norskopinetrar.
FI851637A0 (fi) 1,4-dihydro-4-oxonaftyridinderivat och deras salter, foerfarande foer framstaellning av dessa och dessa omfattande antibakteriella aemnen.
BR7903563A (pt) Processo de formacao de estrutura abobadada e respectiva disposicao construtiva
BG31799A3 (bg) Метод за получаване на хидантоини
FI822990A7 (fi) Rasian suljin.
BG30314A3 (bg) Фунгицидно средство
ES262762Y (es) "estructura de casquillo".
GB2083459B (en) New substituted heterocyclic benzamides and their production
IT7923672A0 (it) Composizioni vulcanizzabili e loro procedimento di fabbricazione.
ATE1500T1 (de) 6-chlor-2,3-dihydroxy-1,4-naphthochinon und seine 2,3-diester, und ihre herstellung.
DK240979A (da) 3-azabicyclo (3,1,0) hexanderivater
NL7903010A (nl) Plantenkweeklichaam.
AR241108A2 (es) Insecticidas piretroides, acidos ciclopropancarboxilicos y esteres intermediarios y sus precedimientos de preparacion
NO792329L (no) 1-fenyl-1-propanol-derivater.
NL7903973A (nl) 1,2,4-triazolidinonen-3 en thionen-3.
DK241079A (da) 3-azabicyclo (3,1,0) hexanderivater
DE3782698D1 (de) 5-fluoruridin-derivat und dessen herstellung.
BE875273A (fr) 0-carbamoyloximes de 2,3-dihydro-4h-1-benzo-pyranne-4-ones
NL185583B (nl) Luchtbehandelingskast.
SU647509A1 (ru) Вентил ционное устройство
IT8524166V0 (it) Pupazzo animato con occhi telescopici.
AU526670B2 (en) Production of 5.6 dihydro-2-methyl-n-phenyl-1,4-oxathiin-3- carboxamide
JPS5517393A (en) Nncyclohexyllnnmethoxyacetoacetoamide*and its use for manufacturing oomethyllnncyclohexyll 2*55dimethylfurann33hydroxamic acid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee